Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 808

    Article Cited by others

REVIEW ARTICLE

Prostate cancer for the internist

Jaiswal Shikha, Sarmad Rehan, Arora Sumant, Dasaraju Radhikha, Sarmad Komal

Year : 2015| Volume: 7| Issue : 10 | Page no: 429-435

   This article has been cited by
 
1 The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer
Xinchun Zhou,Jinghe Mao,Wanxin Peng,Zhenbang Chen,Hao Mei,Patrick Kyle,Yinyuan Mo,Timothy C Allen
Translational Oncology. 2021; 14(12): 101218
[Pubmed]  [Google Scholar] [DOI]
2 Expression Profile of MiR-200 Family Members and Their Targets in Prostate Cancer
Piotr Maryam Khorasani,Shirin Shahbazi,Maryam Abolhasani,Hossein Shahrokh,Reza Mahdian
Cytology and Genetics. 2021; 55(4): 357
[Pubmed]  [Google Scholar] [DOI]
3 Profiling of metabolic biomarkers in the serum of prostate cancer patients
F. Ali,S. Akram,S. Niaz,N. Wajid
The Ukrainian Biochemical Journal. 2020; 92(1): 56
[Pubmed]  [Google Scholar] [DOI]
4 Inactivation of the Wnt/ß-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2
Zhenming Jiang,Yuxi Zhang,Xi Chen,Pingeng Wu,Dong Chen
Cancer Cell International. 2019; 19(1)
[Pubmed]  [Google Scholar] [DOI]
5 Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies
Denisa Baci,Antonino Bruno,Caterina Cascini,Matteo Gallazzi,Lorenzo Mortara,Fausto Sessa,Giuseppe Pelosi,Adriana Albini,Douglas M. Noonan
Journal of Experimental & Clinical Cancer Research. 2019; 38(1)
[Pubmed]  [Google Scholar] [DOI]
6 Association of single nucleotide polymorphism in hsa-miR-499 and hsa-miR-196a2 with the risk of prostate cancer
Ramin Nouri,Saeid Ghorbian
International Urology and Nephrology. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Large Health Systems’ Prevention Guideline Implementation: A Qualitative Study
Julia A. Doherty,Sally J. Crelia,Mark W. Smith,Sarah F. Rosenblum,Ellen M. Rumsey,Iris R. Mabry-Hernandez,Quyen Ngo-Metzger
American Journal of Preventive Medicine. 2018; 54(1): S88
[Pubmed]  [Google Scholar] [DOI]
8 High-performance liquid chromatographic separation of 8-aminopyrene-1,3,6-trisulfonic acid labeled N -glycans using a functional tetrazole hydrophilic interaction liquid chromatography column
Sachio Yamamoto,Mitsuhiro Kinoshita,Toru Ikegami,Shigeo Suzuki
Journal of Chromatography A. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance
Katerina Pestova,Adam J. Koch,Charles P. Quesenberry,Jun Shan,Ying Zhang,Amethyst D. Leimpeter,Beth Blondin,Svetlana Sitailo,Lela Buckingham,Jing Du,Huixin Fei,Stephen K. Van Den Eeden
BMC Cancer. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
10 MicroRNAs and epithelial-mesenchymal transition in prostate cancer
Kirandeep Sekhon,Nathan Bucay,Shahana Majid,Rajvir Dahiya,Sharanjot Saini
Oncotarget. 2016; 7(41): 67597
[Pubmed]  [Google Scholar] [DOI]
11 Current landscape of protein glycosylation analysis and recent progress toward a novel paradigm of glycoscience research
Sachio Yamamoto,Mitsuhiro Kinoshita,Shigeo Suzuki
Journal of Pharmaceutical and Biomedical Analysis. 2016;
[Pubmed]  [Google Scholar] [DOI]
12 Association of ring box-1 protein overexpression with clinicopathologic prognostic parameters in prostate carcinoma
Zeliha Esin Celik,Mehmet Kaynar,Fatma Dobur,Pinar Karabagli,Serdar Goktas
Urologic Oncology: Seminars and Original Investigations. 2016;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article